Among the other molecular subtypes, the lowest excess mortality occurred among women with luminal B (HER2-) tumours, followed by those with luminal B (HER2 +) tumours, HER2-enriched tumours, and TNBC tumours. Here, ERBB2 is linked to neoplasm.